U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

2023
446
Substance Class Protein
Created
by admin
on Wed Apr 02 02:53:41 GMT 2025
Edited
by admin
on Wed Apr 02 02:53:41 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
4W3KFI3TN3
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
Talquetamab
INN   USAN  
Official Name English
JNJ-64407564
Preferred Name English
Talquetamab [WHO-DD]
Common Name English
Immunoglobulin G4 [233-proline,239-alanine,240-alanine,410-leucine,414-lysine], anti-(human CD3 antigen) (human monoclonal JNJ-63483043 ?4-chain), disulfide with human monoclonal JNJ-63483043 ?-chain, (231?224?), (234?227?)-bis(disulfide) with immunoglob
Common Name English
talquetamab [INN]
Common Name English
Immunoglobulin G4-kappa/G4-lambda, anti-[Homo sapiens GPRC5D (G protein-coupled receptor class C group 5 member D)], and anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4)], humanized and chimeric monoclonal antibody; bispecific gamma4 heavy chain humanized an
Common Name English
TALQUETAMAB [USAN]
Common Name English
IMMUNOGLOBULIN G4-KAPPA/G4-LAMBDA, ANTI-(HOMO SAPIENS GPRC5D (G PROTEIN-COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D)), AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY, BISPECIFIC
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 814921
Created by admin on Wed Apr 02 02:53:41 GMT 2025 , Edited by admin on Wed Apr 02 02:53:41 GMT 2025
Code System Code Type Description
DAILYMED
4W3KFI3TN3
Created by admin on Wed Apr 02 02:53:41 GMT 2025 , Edited by admin on Wed Apr 02 02:53:41 GMT 2025
PRIMARY
FDA UNII
4W3KFI3TN3
Created by admin on Wed Apr 02 02:53:41 GMT 2025 , Edited by admin on Wed Apr 02 02:53:41 GMT 2025
PRIMARY
USAN
JK-141
Created by admin on Wed Apr 02 02:53:41 GMT 2025 , Edited by admin on Wed Apr 02 02:53:41 GMT 2025
PRIMARY
CAS
2226212-40-2
Created by admin on Wed Apr 02 02:53:41 GMT 2025 , Edited by admin on Wed Apr 02 02:53:41 GMT 2025
PRIMARY
SMS_ID
300000010796
Created by admin on Wed Apr 02 02:53:41 GMT 2025 , Edited by admin on Wed Apr 02 02:53:41 GMT 2025
PRIMARY
INN
11173
Created by admin on Wed Apr 02 02:53:41 GMT 2025 , Edited by admin on Wed Apr 02 02:53:41 GMT 2025
PRIMARY
NCI_THESAURUS
C171840
Created by admin on Wed Apr 02 02:53:41 GMT 2025 , Edited by admin on Wed Apr 02 02:53:41 GMT 2025
PRIMARY
From To
1_22 1_98
1_139 3_214
1_152 1_208
1_231 2_224
1_234 2_227
1_266 1_326
1_372 1_430
2_22 2_96
2_132 4_214
2_145 2_201
2_259 2_319
2_365 2_423
3_22 3_90
3_137 3_196
4_23 4_88
4_134 4_194
Related Record Type Details
Talquetamab-TGVS
SUB_CONCEPT->SUBSTANCE
T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN
TARGET -> ACTIVATOR
G-PROTEIN COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D
TARGET->LIGAND
CD3
CD3
TARGET -> ACTIVATOR
Related Record Type Details
Talquetamab
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966